有晚期肝病征象且临床显著门静脉高压的患者不一定存在肝硬化
该回顾性研究分析了89例有肝血流动力学数据的疑似肝硬化患者,以肝活检为参考标准,发现肝静脉压力梯度(HVPG)≥10 mm Hg者中16%无肝硬化组织学特征,最常见病因为非酒精性脂肪性肝炎和结节性再生性增生,HVPG≥12 mm Hg诊断肝硬化的特异性为92%。
要点
- HVPG≥10 mm Hg的慢性肝病患者中16%(14/89)肝活检无肝硬化组织学特征。
- 这些患者最常见诊断为非酒精性脂肪性肝炎(n=5)和结节性再生性增生(n=4)。
- HVPG≥12 mm Hg诊断肝硬化的特异性为92%,但误分类5例不同病因肝病患者。
核心结论
- 在89例HVPG≥10 mm Hg的慢性肝病连续患者中,16%经活检分析未发现肝硬化。
- 大多数无肝硬化患者为非酒精性脂肪性肝炎或结节性再生性增生。
- HVPG≥12 mm Hg识别肝硬化患者的特异性为92%。
研究设计与样本
- 回顾性分析2015年至2017年连续收集的157例患者,其中89例疑似肝硬化并有肝血流动力学数据。
- 每例活检标本含10个以上门管区,分析肝硬化特征,排除有肝硬化组织学特征的标本后由专家病理学家复核,纤维化面积通过图像分析数字化计算。
主要发现
- HVPG识别肝硬化患者的受试者工作特征曲线下面积为0.879。
- HVPG≥10 mm Hg的89例患者中14例(16%)无肝硬化组织学特征(METAVIR评分<4且Ishak评分<6),HVPG中位值11 mm Hg(范围10-22 mm Hg)。
- 基于METAVIR评分,7例为F3期纤维化,4例为F2期,3例为F0或F1期;肝纤维化面积平均16.2%±6.5%。
- 14例患者均有窦周纤维化,8例有肝细胞气球样变;最常见诊断为非酒精性脂肪性肝炎(n=5)和结节性再生性增生(n=4)。
- HVPG截止值12 mm Hg识别肝硬化患者的特异性为92%,误分类5例不同病因的肝病患者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Patients with hepatic venous pressure gradients (HVPGs) of 10 mm Hg or greater and chronic liver disease often are assumed to have cirrhosis. We investigated the association between HVPGs and cirrhosis, using histologic findings as the reference standard. We also assessed the prevalence and characteristics of patients with HVPGs of 10 mm Hg or greater without cirrhosis. METHODS: We performed a retrospective analysis of 157 consecutive patients, 89 with suspected cirrhosis and hepatic hemodynamic data collected from 2015 through 2017. Biopsy specimens collected had 10 or more portal tracts from each patient and were analyzed for features of cirrhosis. Biopsy specimens with histologic features of cirrhosis were excluded and the remaining biopsy specimens were re-reviewed by an expert pathologist. The fibrosis area was calculated digitally by image analysis. RESULTS: HVPG identified patients with cirrhosis with an area under the receiver operating characteristic curve of 0.879: 14 of 89 patients with HVPG of 10 mm Hg or greater (16%) had no histologic features of cirrhosis (METAVIR scores <4 and Ishak scores <6). The median HVPG was 11 mm Hg (range, 10-22 mm Hg). Based on METAVIR scores, 7 patients had fibrosis stage F3, 4 patients had fibrosis stage F2, and 3 patients had fibrosis stages F0 or F1. The mean area of fibrosis in livers was 16.2% ± 6.5%. All 14 patients had perisinusoidal fibrosis and 8 patients had hepatocyte ballooning. The most common diagnoses were nonalcoholic steatohepatitis (n = 5) and nodular regenerative hyperplasia (n = 4). An HVPG cut-off value of 12 mm Hg identified patients with cirrhosis with 92% specificity, misclassifying 5 patients with different etiologies of liver disease. CONCLUSIONS: In a retrospective analysis of 89 consecutive patients with chronic liver disease and an HVPG of 10 mm Hg or greater, 16% were not found to have cirrhosis upon biopsy analysis. Most of these patients had nonalcoholic steatohepatitis or nodular regenerative hyperplasia. Perisinusoidal fibrosis and hepatocyte ballooning might increase sinusoidal pressure. An HVPG cut-off value of 12 mm Hg or greater identified patients with cirrhosis with 92% specificity.
引用
- Rodrigues SG, Montani M, Guixé-Muntet S, et al. Patients With Signs of Advanced Liver Disease and Clinically Significant Portal Hypertension Do Not Necessarily Have Cirrhosis. Clin Gastroenterol Hepatol. 2019. PMID: 30625404. doi:10.1016/j.cgh.2018.12.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。